DTC/OTC Infectious Disease Diagnostics: Strategies and Trends for Direct-to-Consumer and Over the Counter, Market Forecasts by Application, Channel and Country with Market Analysis, Executive Guides and Market Opportunity Analysis 2023 to 2027
Publication date: March 6, 2023
Page count: 479
“The end of the pandemic opens up a new market for diagnostic technology….”
Exciting technical developments (especially in the seesaw between PCR and immunoassay) hold the promise of a dynamic, growing and evolving world market that holds the promise of diagnostics taking the lead in infectious disease eradication. Even CRISPR diagnostics are now coming into play.
The report breaks forecasts out to 2027 by the following:
- Syndrome; Respiratory, STD, UTI, HxV, Other
- Channel; OTC, DTC HSG
- Country; USA, Canada, Germany, France, UK, RoEUR, Japan, China, S. Korea, RoAP, Brazil, Mexico, RoLA, ME&A, Global
Our research makes you the expert in your organization. Get our research team working for you by ordering this comprehensive report. Check all your licensing options, however your order is available as a credit if you wish to upgrade. We wrote this report and are ready by phone or email to help you use it.
All report data is available in Excel format on request with the corporate license.
ABOUT THE LEAD AUTHOR
Mr. Greg Powell, B.SC., M.B.A is an experienced business and clinical professional. He is co-author of the paper "The Radioimmunoassay of Angiotensinogen by Antibody Trapping." He has worked in laboratory testing and management for over 20 years. Mr. Powell’s education includes:
- B.Sc. (Chemistry) University of BC
- M.B.A. (Finance and Policy) University of BC
- Market Research Seminar - Burke Institute
- Finance for Senior Executives - Harvard Business School